Dyadic Creative Arts Therapies-based Intervention for Children With Intellectual and Devel
Background: Interactions between parents and children with intellectual and developmental disabilities (IDD) tend to be directive and didactic lacking in playfulness and enjoyment. Recent research has shown that parents of children with IDD who engage in more playful, creative, and enjoyable interactions tend to foster
| Condition(s) | Intellectual Disabilities Global Developmental Delay |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Background: Interactions between parents and children with intellectual and developmental disabilities (IDD) tend to be directive and didactic lacking in playfulness and enjoyment. Recent research has shown that parents of children with IDD who engage in more playful, creative, and enjoyable interactions tend to foster more positive relationships with their children. Early interventions have been shown to enhance parent-child interactions and promote cognitive and socio-emotional development in children with IDD. Objectives: This mixed-methods randomized controlled trial (RCT) study aims to develop a manualized dyadic Creative-Art-Therapies (CAT)-based intervention for children with IDD and their mothers and assess and explore its effects on the quality of the mother-child interaction and |
| Who can participate | Inclusion Criteria: * Children between the age of 3-7 * Children with a prior diagnosis of IDD, or studying in special education nursery schools for children with developmental delays * The children's mothers Exclusion Criteria: * Children with additional primary diagnosis of autism spectrum disorder or cerebral palsy * Children with additional diagnosis of severe physical disability or serious movement limitations * Children with additional diagnosis of sensory disorders such as blindness or deafness |
| Ages | 3 Years to 7 Years |
| Sex | All |
| Lead sponsor | University of Haifa |
| Locations | Haifa, Israel |
| Start date | 2024-02-22 |
| NCT ID | NCT06541782 |
| Official listing | https://clinicaltrials.gov/study/NCT06541782 |